RESEARCH REPORTS

Institutional Analyst Inc.


Subscribe to receive next report on Society Pass.

Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea Ever.


Argus Research Report

NEW YORK, NY, Dec. 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Argus Research Co (“Argus”) issues Equity Research Report on Society Pass Incorporated (Nasdaq: SOPA), SEA’s leading data-driven loyalty, fintech and e-commerce ecosystem. Press Release.


Maxim Investment Bankers Report

New York, NY, Nov. 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Maxim Group LLC (“Maxim”) issues Equity Research Report on Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), SEA’s leading data-driven loyalty, fintech and e-commerce ecosystem. Press Release.


Spartan Capital Investment Bankers Report

New York, NY, July 26, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Spartan Capital Securities LLC (“Spartan Capital”) issues Equity Research Report on Society Pass Inc. (Nasdaq: SOPA) (“SoPa”). Press Release.


See each respective report for disclosure and disclaimer details.

Cautionary Note Concerning Forward-Looking Statements
These reports may include “forward-looking statements,” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus relating to the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

SEC disclosure filings.